From structural biology to precision medicine-decoding the key receptor in thyroid disorders.

Authors

Fei Wang, Hui Chen

Published in

Drug discovery today. Pages 104766. Aug 12, 2026. Epub Aug 12, 2026.

Abstract

The thyroid‑stimulating hormone receptor (TSHR), a major autoantigen, has become a druggable precision‑medicine target in thyroid disorders. Recent cryo‑EM advances have clarified the dual‑mode activation and allosteric landscape of this receptor, boosting the development of novel therapeutics that include blocking antibodies, pathway‑specific small molecules and TSHR-IGF‑1R crosstalk inhibitors. Functional antibody subtyping and receptor‑targeted imaging also improve diagnostic accuracy. This review summarizes TSHR translational progress, illustrating how mechanistic findings support novel diagnostics, targeted agents and curative immunotherapies.

PMID:
42586473
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.